25 May 2013
Keywords: gsk, offers, employers, relenza, flu, vaccine, option
Article | 08 September 2008
Through its US office, UK-based drug major GlaxoSmithKline has announced the launch of the Relenza (zanamivir) Inhalation Powder Pandemic
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
8 September 2008
24 May 2013
© 2013 thepharmaletter.com